Elutia (ELUT) Scheduled to Post Quarterly Earnings on Thursday

Elutia (NASDAQ:ELUT) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, November 14th.

Elutia Stock Performance

ELUT stock opened at $3.80 on Tuesday. The stock has a market cap of $129.43 million, a P/E ratio of -1.33 and a beta of 0.76. The stock’s fifty day simple moving average is $3.76 and its two-hundred day simple moving average is $3.67. Elutia has a 1-year low of $1.39 and a 1-year high of $5.24.

Analyst Upgrades and Downgrades

Separately, Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price target on shares of Elutia in a report on Friday, September 6th.

Elutia Company Profile

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.